US imaging and color Doppler in patients undergoing inhibitory therapy with calcitriol for secondary hyperparathyroidism
- 39 Downloads
- 4 Citations
Abstract
The aim of this study was to evaluate the changes in volume, structure, and flow pattern of parathyroid glands in uremic patients with secondary hyperparathyroidism treated with long-term intravenous calcitriol (CTL) therapy. Ultrasonography was used to follow-up volume changes occurring in 18 enlarged glands in 11 patients during an 18-month period; in 6 of these cases, 11 glands were followed-up also with color-Doppler to monitor variations in flow pattern. Vascularization was classified using three grades: grade 0=no color signal; grade I=vessels covering less than 50% of glandular cross-sectional area; grade II=vascular signals covering more than 50% of glandular cross-sectional area. No significant changes in volume were demonstrated during the 18 months of follow-up. On the contrary, significant decrease in flow was observed with almost complete disappearance of color-Doppler signals. This finding related well with the observed decrease in parathormone blood levels. Lack of volume changes during medical therapy demonstrates the inability of US alone to monitor the effect of this treatment on the parathyroid glands. Conversely, the observed intraglandular flow reduction indicates the possibility to use color Doppler to monitor the effects of CLT in uremic hemodialyzed patients with secondary hyperparathyroidism. This imaging procedure can be proposed for follow-up of the response of the parathyroid glands to therapy.
Key words
Parathyroid Hyperparathyroidism US studies Color-Doppler USPreview
Unable to display preview. Download preview PDF.
References
- 1.Llach F, Bover J (1996) Renal osteodystrophy. In: Brenner BM (ed) The kidney, 5th edn. Saunders, Philadelphia, pp 2245–2253Google Scholar
- 2.Slatopolsky E, Weerts C, Thierlan J, Horst R, Harter H, Martin KJ (1984) Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-Dihydroxycholecalciferol in uremic patients. J Clin Invest 74: 2136–2143PubMedGoogle Scholar
- 3.Delmez DA, Tindira C, Grooms P, Dusso A, Windus DW, Slatopolsky E (1989) Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. J Clin Invest 83: 1349–1355PubMedCrossRefGoogle Scholar
- 4.Cannella G, Bonucci E, Rolla D, Ballanti P, Moriero E, Grandi R de, Augeri C, Claudiani F, Di Maio G (1994) Evidence of healing of secondary hyperparathyroidism in chronically hemodialyzed uremic patients treated with long-term intravenous calcitriol. Kidney Int 46: 1124–1132PubMedCrossRefGoogle Scholar
- 5.Fukagawa M, Okazaki R, Takano K, Kaname S-Y, Ogata E, Kitaoka M, Harada S-I, Sekene N, Matsumoto T, Kurokawa K (1990) Regression of parathyroid hyperplasia by calcitriol-pulse therapy in patients on long-term dialysis. N Engl J Med 323: 421–422PubMedCrossRefGoogle Scholar
- 6.Quarles LD, Yohay DA, Carroll B, Spritzer CE, Minda S, Lobaugh B (1993) Prospective double-blind placebo-controlled trial of pulse oral (PO) versus intravenous (IV) calcitriol in the treatment of hyperparathyroidism in end-stage renal disease (ESRD; abstract). J Am Soc Nephrol 4: 718Google Scholar
- 7.Solbiati L, Giangrande A, De Pra L, Bellotti E, Cantù P, Ravetto C (1985) Percutaneous ethanol injection of parathyroid tumors under US guidance: treatment for secondary hyperparathyroidism. Radiology 155: 607–610PubMedGoogle Scholar
- 8.Graif M, Itzchak Y, Strauss S, Dolev E, Mohr R, Wolfstein I (1987) Parathyroid sonography: diagnostic accuracy related to shape, location and texture of the gland. Br J Radiol 60: 439–443PubMedCrossRefGoogle Scholar
- 9.Takebayashi S, Matsui K, Onohara Y, Hidai H (1987) Sonography for early diagnosis of enlarged parathyroid glands in patients with secondary hyperparathyroidism. Am J Roentgenol 148: 911–914Google Scholar
- 10.Solbiati L, Cioffi V, Ballarati E (1992) Ultrasonography of the neck. Radiol Clin North Am 30: 941–954PubMedGoogle Scholar
- 11.Gooding GAW (1993) Sonography of the thyroid and parathyroid. Radiol Clin North Am 31: 967–989PubMedGoogle Scholar
- 12.Fugazzola C, Bergamo Andreis I, Solbiati L (1995) Parathyroid glands. In: Rizzatto G, Solbiati L (eds) Ultrasonography of superficial structures. Churchill Livingstone, Edinburgh, pp 87–113Google Scholar
- 13.Schulthness GK von, Baumann R, Weder W, Duewell S (1993) MRI, CT, sonography and thallium-technetium subtraction scintigraphy for the detection of parathyroid disease: a four-year experience. Eur Radiol 3: 71–76Google Scholar
- 14.Calliada F, Bergonzi M, Passamonti C, Campani R, Bottinelli O, Genovese E, Beluffi G, Bozzetti E, Corsi G, Bozzini A (1989) Il contributo del color-Doppler nello studio ecografico delle ghiandole paratiroidi iperplastiche. Radiol Med 78: 607–611PubMedGoogle Scholar
- 15.Solbiati L, Rizzatto G, Ballarati E, Ierace T, Crespi L (1993) Practical implications of color-Doppler sonography of parathyroid glands: study of 203 tumors. Radiology 189 (P): 210Google Scholar
- 16.Ierace T, Ballarati E, Crespi L, Solbiati L (1994) Use of power-Doppler US in percutaneous ethanol injection of parathyroid tumors. Radiology 193 (P): 232Google Scholar